Cargando…

Retracted: Silencing of Exosomal miR‐296‐5p Derived from Endothelial Progenitor Cells Enhances Thrombolysis and Recanalization in Deep Vein Thrombosis

Retraction: Wang, J., Yang, Z., Liu, S., Zhang, L., & Zhao, Y. Silencing of Exosomal miR‐296‐5p Derived from Endothelial Progenitor Cells Enhances Thrombolysis and Recanalization in Deep Vein Thrombosis, Clin. Trans. Sci. https://ascpt.onlinelibrary.wiley.com/doi/full/10.1111/cts.12799 The above...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504822/
https://www.ncbi.nlm.nih.gov/pubmed/32407604
http://dx.doi.org/10.1111/cts.12799
Descripción
Sumario:Retraction: Wang, J., Yang, Z., Liu, S., Zhang, L., & Zhao, Y. Silencing of Exosomal miR‐296‐5p Derived from Endothelial Progenitor Cells Enhances Thrombolysis and Recanalization in Deep Vein Thrombosis, Clin. Trans. Sci. https://ascpt.onlinelibrary.wiley.com/doi/full/10.1111/cts.12799 The above article, published online on May 14, 2020 in Wiley Online Library has been retracted by agreement among the journal Editor‐in‐Chief, Dr. John Wagner, the American Society for Clinical Pharmacology and Therapeutics, and John Wiley & Sons, Inc. The editors had concerns about the validity of the Western blot and qPCR data presented in the article. The authors provided raw data, and software image integrity analysis has confirmed the journal's suspicions that the Western blots have been inappropriately manipulated. The authors disagree with the decision to retract this manuscript.